A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
about
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanomaTargeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination.Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer.An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR TherapySuppression of c-MET overcomes erlotinib resistance in tongue cancer cells
P2860
Q33761715-1A1150D6-B8C3-4F23-A275-5D9AC7E2DC9AQ36115818-5200039F-A35C-474C-A0A3-65094613AB23Q36174467-955E0379-8B57-4B32-8995-AEC75D2EBEFBQ38587550-7AC5FDED-7E33-4C1F-B9C2-FD164DEF42A9Q38623361-11215BFD-3C15-4FAA-832B-8577FEB78105Q38800568-DDACF587-B207-4533-AA42-37C22E1E49F2Q38922319-359D20A5-9C88-4ECE-8832-8E9213FB7E46Q39085589-2B46F001-E8DC-4246-99F5-CE2C817235C0Q47913256-E47D7C28-6058-49D8-85D3-D446E40E6121Q51091805-3BEC6652-C20C-47A0-8DAF-D3D4D28B4794Q53251841-1CEA082B-DE1D-4908-851B-C304A37D7198Q58693496-63C6871C-DCF4-4A6B-87F3-09F721BDE17EQ58762813-5469497B-F538-4427-89B1-56B682A9E110
P2860
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@ast
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@en
type
label
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@ast
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@en
prefLabel
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@ast
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@en
P2093
P2860
P356
P1433
P1476
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.
@en
P2093
A Rabinkov
C-R Pradeep
N Ben-Chetrit
S Carvalho
W J Köstler
P2860
P2888
P304
P356
10.1038/ONC.2011.518
P407
P577
2011-11-21T00:00:00Z